• By Vivek Raj
  • Fri, 05 Jan 2024 02:29 PM (IST)
  • Source:ANI

The Union Home Ministry has reportedly directed the Central Bureau of Investigation (CBI) to conduct a thorough inquiry into the alleged procurement and supply of spurious and non-standard drugs in hospitals run by the Delhi government and Mohalla clinics

In December, Delhi LG asked for a CBI probe into into alleged supply of substandard medicines to Delhi government hospitals.

Earlier on Thursday, Delhi Lt Governor V K Saxena had recommended the alleged corruption in the diagnostic tests done at Mohalla clinics, as reported by news agency ANI. It is alleged that Mohalla clinics used to conduct fake radiology and pathology tests without any patients.

ALSO READ: Liberian-Flagged Ship With 15 Indian Crew Hijacked Off Somalia's Coast, INS Chennai Moves In To Tackle Situation

A day after Lieutenant Governor V K Saxena recommended a CBI investigation, details have emerged about alleged fraudulent practices in seven Mohalla Clinics in Delhi. The scam revealed through a Vigilance department inquiry, involves irregularities in conducting medical tests on dummy patients, resulting in payments to private diagnostic firms.

Delhi government's Directorate of Vigilance had on December 26 written to the Union Home Ministry, requesting it to assign the investigation into the supply of "sub-standard" drugs to state-run hospitals to the CBI.

Delhi Vigilance Minister Saurabh Bharadwaj wrote to the Health Secretary about the supply of 'not of standard quality' drugs in the national capital, urging the latter to procure alternative arrangements.

"It has been brought to my notice that the Vigilance Department, GNCTD, has directed the secretary (health) to immediately remove the five drugs that were 'not of standard quality', from the stock where they have been supplied," read the letter.

ALSO READ: AAP Nominates DCW Chief Swati Maliwal For Rajya Sabha; Sanjay Singh, ND Gupta Renominated

"You are directed to inform me regarding the alternative arrangements made by DGHS and the hospitals for making available the five medicines, amlodipine, levetiracetam, pantoprazole, cephalexin, and dexamethasone, of standard quality and their fresh stock position in the healthcare facilities, at the latest within a week," it added.